Cargando…
Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms
Mesenchymal stem cells (MSC) display tumor tropism and have been addressed as vehicles for delivery of anti-cancer agents. As cellular components of the tumor microenvironment, MSC also influence tumor progression. However, the contribution of MSC in brain cancer is not well understood since either...
Autores principales: | Rodini, Carolina Oliveira, Gonçalves da Silva, Patrícia Benites, Assoni, Amanda Faria, Carvalho, Valdemir Melechco, Okamoto, Oswaldo Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973871/ https://www.ncbi.nlm.nih.gov/pubmed/29872504 http://dx.doi.org/10.18632/oncotarget.25346 |
Ejemplares similares
-
RNAi-mediated knockdown of E2F2 inhibits tumorigenicity of human glioblastoma cells
por: NAKAHATA, ADRIANA M., et al.
Publicado: (2014) -
High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells
por: Gonçalves da Silva, Patrícia Benites, et al.
Publicado: (2017) -
Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
por: Pereira, Marcia C. L., et al.
Publicado: (2011) -
miR‐367 as a therapeutic target in stem‐like cells from embryonal central nervous system tumors
por: Kaid, Carolini, et al.
Publicado: (2019) -
Sprouty2 enhances the tumorigenic potential of glioblastoma cells
por: Park, Jong-Whi, et al.
Publicado: (2018)